First-trimester contingent screening for trisomies 21, 18 and 13 by fetal nuchal translucency and ductus venosus flow and maternal blood cell-free DNA testing

Replacing the Combined Test by Cell-Free DNA Testing in Screening for Trisomies 21, 18 and 13: Impact on the Diagnosis of Other Chromosomal Abnormalities

(2014) Argyro Syngelaki et al.   FETAL DIAGNOSIS AND THERAPY

Analysis of Cell-Free DNA in Maternal Blood in Screening for Aneuploidies: Meta-Analysis

(2014) M.M. Gil et al.   FETAL DIAGNOSIS AND THERAPY

DNA Sequencing versus Standard Prenatal Aneuploidy Screening

(2014) Diana W. Bianchi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Model-Based Analysis of Costs and Outcomes of Non-Invasive Prenatal Testing for Down’s Syndrome Using Cell Free Fetal DNA in the UK National Health Service

(2014) Stephen Morris et al.   PLoS One

Screening for trisomies 21, 18 and 13 by cell-free DNA analysis of maternal blood at 10-11 weeks' gestation and the combined test at 11-13 weeks

(2014) M. S. Quezada et al.   ULTRASOUND IN OBSTETRICS & GYNECOLOGY

First-Trimester Contingent Screening for Trisomies 21, 18 and 13 by Biomarkers and Maternal Blood Cell-Free DNA Testing

(2013) K.H. Nicolaides et al.   FETAL DIAGNOSIS AND THERAPY

First-Trimester Screening for Trisomies 21, 18 and 13 by Ultrasound and Biochemical Testing

(2013) D. Wright et al.   FETAL DIAGNOSIS AND THERAPY

Noninvasive prenatal testing of fetal aneuploidies by massively parallel sequencing in a prospective Chinese population

(2013) Yijun Song et al.   PRENATAL DIAGNOSIS

Maternal cfDNA screening for Down syndrome - a cost sensitivity analysis

(2013) Howard Cuckle et al.   PRENATAL DIAGNOSIS

First-trimester contingent screening for trisomy 21 by biomarkers and maternal blood cell-free DNA testing

(2013) K. H. Nicolaides et al.   ULTRASOUND IN OBSTETRICS & GYNECOLOGY

Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population

(2012) Kypros H. Nicolaides et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

A Mixture Model of Ductus Venosus Pulsatility Index in Screening for Aneuploidies at 11–13 Weeks’ Gestation

(2012) Nerea Maiz et al.   FETAL DIAGNOSIS AND THERAPY

Two-stage first-trimester screening for trisomy 21 by ultrasound assessment and biochemical testing

(2010) K. O. Kagan et al.   ULTRASOUND IN OBSTETRICS & GYNECOLOGY

Ductus venosus Doppler in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation

(2009) N. Maiz et al.   ULTRASOUND IN OBSTETRICS & GYNECOLOGY

Fetal nasal bone in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation

(2009) K. O. Kagan et al.   ULTRASOUND IN OBSTETRICS & GYNECOLOGY

Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free  -hCG and pregnancy-associated plasma protein-A

(2008) K. O. Kagan et al.   HUMAN REPRODUCTION

Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A

(2008) K. O. Kagan et al.   ULTRASOUND IN OBSTETRICS & GYNECOLOGY

Tricuspid regurgitation in screening for trisomies 21, 18 and 13 and Turner syndrome at 11 + 0 to 13 + 6 weeks of gestation

(2008) K. O. Kagan et al.   ULTRASOUND IN OBSTETRICS & GYNECOLOGY